HUTCHMED Announces that Inmagene Exercises Option to
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
Source: globenewswire.com
Stay updated with breaking news from Crossley Daphne. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13)...
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., Feb. 02, 2024 -- HUTCHMED Limited today announced that, Inmagene Biopharmaceuticals has exercised options to license two drug candidates...